| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,618 |
16,848 |
$1.23M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,507 |
9,266 |
$946K |
| 80053 |
Comprehensive metabolic panel |
4,606 |
4,553 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,755 |
3,705 |
$27K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,076 |
1,994 |
$26K |
| 80061 |
Lipid panel |
1,676 |
1,674 |
$20K |
| 99051 |
|
1,556 |
1,511 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
496 |
496 |
$8K |
| 84439 |
|
484 |
483 |
$4K |
| 90688 |
|
179 |
179 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
162 |
154 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
196 |
194 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
22 |
16 |
$1K |
| 81001 |
|
82 |
81 |
$235.83 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$127.80 |
| 90686 |
|
13 |
13 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
14 |
14 |
$0.00 |